Breaking from tradition. Ignite the path to a cure.

Drug response reports: a foundation for the accelerated development of new cancer treatments.

[fa icon='calendar'] Jun 3, 2021 8:25:05 AM / by David Deems posted in Drug Response Data

[fa icon="comment"] 0 Comments

The purpose of Cellaria’s in vitro cancer cell models is to accelerate clinical studies by facilitating the study of disease within specific and unique patient biology. We use our expertise in cell line growth, stabilization, and characterization to provide tools that answer directly to the requirements of those at the cutting edge of oncology research. While the models are our core product, we think hard about the information provided with them to ensure that researchers choose the most suitable model and use it productively from the get-go. 

Read More [fa icon="long-arrow-right"]

New Lung Cancer Cell Lines for a Diverse Patient Cohort

[fa icon='calendar'] May 25, 2021 1:00:00 PM / by David Deems posted in Lung Cancer Cell Models , Drug Response Data

[fa icon="comment"] 0 Comments

A diverse patient cohort for non-small cell lung cancer

Read More [fa icon="long-arrow-right"]